{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:21:52Z","timestamp":1793467312529,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>Rare cases of aggressive B-cell lymphomas with a morphology similar to Burkitt lymphoma (BL) present with the BL-typical immunophenotype, but lacked <jats:italic toggle=\"yes\">MYC<\/jats:italic> translocation (<jats:italic toggle=\"yes\">MYC<\/jats:italic>-negative Burkitt-like lymphoma: mnBLL). A proportion of those with an imbalance pattern in chromosome 11q has been designated <jats:italic toggle=\"yes\">Burkitt-like lymphoma with 11q aberration<\/jats:italic> in the recent update of the World Health Organization (WHO) classification. Because of the problems in the identification of Burkitt-like lymphoma with 11q aberration, our goal was to retrospectively analyze their frequency in a cohort of \u201ccandidate\u201d aggressive lymphomas (cohort 1, n=35) such as mnBLL (n=16), diffuse large B-cell lymphoma with similarities to Burkitt lymphoma (DLBCL-BL; n=3), high-grade B-cell lymphomas, not otherwise specified (NOS) (n=16), as well as in a cohort of <jats:italic toggle=\"yes\">MYC<\/jats:italic>-negative diffuse large B-cell lymphoma NOS (cohort 2, n=62). In total, 17\/33 cohort 1 cases (52%) harbored the typical 11q aberration pattern, predominantly those that had been classified as mnBLL (12\/16, 75%), but also as DLBCL-BL (2\/3, 67%) and high-grade B-cell lymphomas, NOS (3\/14; 21%). The specimens with this typical 11q aberration pattern were usually negative for the BCL2 protein. Of interest and as a new finding, samples harboring the 11q aberration pattern were often characterized by strikingly coarse apoptotic debris within starry sky macrophages facilitating their recognition. In contrast, only 1 of 62 garden variety DLBCL, NOS was positive for the 11q aberration pattern. In 2 DLBCL-BL, a dual <jats:italic toggle=\"yes\">MYC<\/jats:italic> translocation\/11q aberration pattern was detected. As a diagnostic algorithm, we, therefore, propose analysis of 11q status in <jats:italic toggle=\"yes\">MYC<\/jats:italic>-negative high-grade lymphomas with features of BL, especially showing BCL2 negativity and a conspicuous coarse apoptotic debris in starry sky macrophages.<\/jats:p>","DOI":"10.1097\/pas.0000000000001613","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T02:04:04Z","timestamp":1604282644000},"page":"356-364","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":49,"title":["A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas"],"prefix":"10.1097","volume":"45","author":[{"given":"Heike","family":"Horn","sequence":"first","affiliation":[{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology"},{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart"},{"name":"University of T\u00fcbingen, T\u00fcbingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Kalmbach","sequence":"additional","affiliation":[{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology"},{"name":"University of T\u00fcbingen, T\u00fcbingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabea","family":"Wagener","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm"},{"name":"Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children\u2019s Hospital, Medical Faculty, Heinrich-Heine-University D\u00fcsseldorf, D\u00fcsseldorf"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette M.","family":"Staiger","sequence":"additional","affiliation":[{"name":"Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology"},{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart"},{"name":"University of T\u00fcbingen, T\u00fcbingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"H\u00fcttl","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Mottok","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Bens","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Traverse-Glehen","sequence":"additional","affiliation":[{"name":"Service d\u2019Anatomie Pathologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-B\u00e9nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Fontaine","sequence":"additional","affiliation":[{"name":"Service d\u2019Anatomie Pathologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-B\u00e9nite, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[{"name":"Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Universit\u00e4t W\u00fcrzburg and Comprehensive Cancer Center Mainfranken (CCCMF), W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood-2018-02-778480","article-title":"Management of aggressive B-cell NHLs in the AYA population: An adult vs pediatric perspective","volume":"132","author":"Dunleavy","year":"2018","journal-title":"Blood"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","article-title":"Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group","volume":"190","author":"Au-Yeung","year":"2020","journal-title":"Br J Haematol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1182\/blood.2019002600","article-title":"The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH","volume":"134","author":"Hilton","year":"2019","journal-title":"Blood"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.3324\/haematol.2018.207290","article-title":"False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms","volume":"104","author":"King","year":"2019","journal-title":"Haematologica"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.3324\/haematol.2018.208140","article-title":"Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of \u201cMYC-negative\u201d Burkitt lymphoma","volume":"105","author":"Wagener","year":"2020","journal-title":"Haematologica"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s12032-010-9614-0","article-title":"Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement","volume":"28","author":"Pienkowska-Grela","year":"2011","journal-title":"Med Oncol"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gcc.22014","article-title":"High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas","volume":"52","author":"Salaverria","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1182\/blood-2013-01-475772","article-title":"Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma","volume":"122","author":"Bonetti","year":"2013","journal-title":"Blood"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3324\/haematol.2017.181024","article-title":"Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2","volume":"103","author":"Horn","year":"2018","journal-title":"Haematologica"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"e95047","DOI":"10.1371\/journal.pone.0095047","article-title":"Numerical and structural genomic aberrations are reliably detectable in tissue microarrays of formalin-fixed paraffin-embedded tumor samples by fluorescence in-situ hybridization","volume":"9","author":"Horn","year":"2014","journal-title":"PLoS ONE"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.prp.2014.09.009","article-title":"Fluorescence in situ analysis of soft tissue tumor associated genetic alterations in formalin-fixed paraffin-embedded tissue","volume":"210","author":"Horn","year":"2014","journal-title":"Pathol Res Pract"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/sj.leu.2404340","article-title":"Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2","volume":"20","author":"Einerson","year":"2006","journal-title":"Leukemia"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/gcc.20009","article-title":"Interphase fluorescence in situ hybridization for detection of 8q24\/MYC breakpoints on routine histologic sections: Validation in Burkitt lymphomas from three geographic regions","volume":"40","author":"Haralambieva","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ajcp\/aqx139","article-title":"The 11q-gain\/loss aberration occurs recurrently in MYC-negative Burkitt-like Lymphoma With 11q aberration, as well as MYC-positive Burkitt lymphoma and MYC-positive high-grade B-cell lymphoma, NOS","volume":"149","author":"Grygalewicz","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cancergen.2015.12.005","article-title":"The peculiar 11q-gain\/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma","volume":"209","author":"Havelange","year":"2016","journal-title":"Cancer Genet"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T22:04:56Z","timestamp":1749420296000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001613","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,30]]}}}